These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15555366)

  • 1. [Application of exponent curve model to study the hepatitis B DNA recombinant yeast derived vaccine antibody levels].
    Luo FJ; Dong CM; Shen YG; Huang CJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):805-7. PubMed ID: 15555366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of immune effect of nine kinds of recombinant hepatitis B vaccines made in China and foreign countries.
    Jing Q; Ren L; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):349-51. PubMed ID: 11471023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in adults].
    Shi J; Wang X; Wang G; Xu Z; Yang Z; Zheng L; Li Z; Guo N; Wu X; Liang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Nov; 36(6):366-9. PubMed ID: 12641969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine (YDV) on adults].
    Shi J; Li Z; Zheng L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Apr; 22(2):105-7. PubMed ID: 11860855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru].
    Lozano M A; Caycho O J; Antunez de Mayolo A; Vera D; Posadas R D
    Rev Gastroenterol Peru; 2003; 23(4):259-64. PubMed ID: 14716420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration.
    Hassan S; Ziba F
    Vaccine; 2007 Apr; 25(17):3511-4. PubMed ID: 17400337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.
    McMahon BJ; Dentinger CM; Bruden D; Zanis C; Peters H; Hurlburt D; Bulkow L; Fiore AE; Bell BP; Hennessy TW
    J Infect Dis; 2009 Nov; 200(9):1390-6. PubMed ID: 19785526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.